Immunopathogenesis of Graves' ophthalmopathy: The role of the TSH receptor

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 26, Issue 3, 2012, Pages 281-289

  Iyer, Seethalakshmi ^a   Bahn, Rebecca ^a  

^a MAYO CLINIC   (United States)

Author keywords

autoimmune disease; Graves' disease; Graves' orbitopathy; thyrotropin receptor; thyrotropin receptor autoantibodies

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AUTOANTIGEN; HYALURONIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ADIPOGENESIS; CELL FUNCTION; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; GENE EXPRESSION; HUMAN; IMMUNOPATHOGENESIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THYROID FOLLICLE CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; LIGANDS; MOLECULAR TARGETED THERAPY; ORBIT; RECEPTOR, IGF TYPE 1; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION;

EID: 84861534372     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2011.10.003     Document Type: Review

References (71)

1. R.S. Bahn Graves' ophthalmopathy New England Journal of Medicine 362 2010 726 738
2. S.M. McLachlan, M.F. Prummel, and B. Rapoport Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue Journal of Clinical Endocrinology Metabolism 78 1994 1070 1074 (Pubitemid 24143025)
3. T.J. Smith, R.S. Bahn, and C.A. Gorman Connective tissue, glycosaminoglycans, and diseases of the thyroid Endocrine Reviews 10 1989 366 391 (Pubitemid 19223067)
4. R.L. Anderson, J.P. Tweeten, and J.R. Patrinely Dysthyroid optic neuropathy without extraocular muscle involvement Ophthalmic Surgery 20 1989 568 574 (Pubitemid 19210253)
5. G. Forbes, C.A. Gorman, and M.D. Brennan Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle American Journal of Neuroradiology 7 1986 651 656 (Pubitemid 16099150)
6. N.I. Regensburg, W.M. Wiersinga, and T.T. Berendschot Do subtypes of Graves' orbitopathy exist? Ophthalmology 118 2011 191 196
7. W.M. Wiersinga, T. Smit, and R. van der Gaag Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease Journal of Endocrinological Investigation 11 1988 615 619
8. S.E. Feldon, D.J. Park, and C.W. O'Loughlin Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy Investigative Ophthalmology and Visual Science 46 2005 3913 3921 (Pubitemid 44264589)
9. B. Grubeck-Loebenstein, K. Trieb, and A. Sztankay Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts Journal of Clinical Investigation 93 1994 2738 2743 (Pubitemid 24177194)
10. E. Otto, G. Forster, and K. Kuhlemann TSH receptor in endocrine autoimmunity Clinical and Experimental Rheumatology 14 Suppl. 15 1996 S77 S84
11. B.S. Prabhakar, R.S. Bahn, and T.J. Smith Current perspective on the pathogenesis of Graves' disease and ophthalmopathy Endocrine Reviews 24 2003 802 835 (Pubitemid 38067700)
12. A. Pappa, J.M. Lawson, and V. Calder T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy British Journal of Ophthalmology 84 2000 517 522 (Pubitemid 30251714)
13. T.J. Smith, L. Koumas, and A. Gagnon Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy Journal of Clinical Endocrinology and Metabolism 87 2002 385 392 (Pubitemid 34084719)
14. L. Koumas, T.J. Smith, and R.P. Phipps Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes European Journal of Immunology 32 2002 477 485 (Pubitemid 34173339)
15. T.K. Khoo, M.J. Coenen, and A.R. Schiefer Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts from patients with Graves' ophthalmopathy Thyroid 2008
16. B. Rapoport, G.D. Chazenbalk, and J.C. Jaume The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies Endocrine Reviews 19 1998 673 716 (Pubitemid 128506520)
17. D.H. Khoo, P.H. Eng, and S.C. Ho Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels Thyroid 10 2000 1093 1100 (Pubitemid 32095079)
18. M.N. Gerding, J.W. van der Meer, and M. Broenink Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy Clinical Endocrinology 52 2000 267 271 (Pubitemid 30169681)
19. S.D. Lytton, K.A. Ponto, and M. Kanitz A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy Journal of Clinical Endocrinology and Metabolism 95 2010 2123 2131
20. X.G. Vos, N. Smit, and E. Endert Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study Clinical Endocrinology (Oxford) 69 2008 311 317 (Pubitemid 352009024)
21. A.K. Eckstein, M. Plicht, and H. Lax Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease Journal of Clinical Endocrinology and Metabolism 91 2006 3464 3470 (Pubitemid 44402120)
22. R.S. Bahn, C.M. Dutton, and W. Joba Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin Thyroid 8 1998 193 196 (Pubitemid 28103609)
23. A. Feliciello, A. Porcellini, and I. Ciullo Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue Lancet 342 1993 337 338 (Pubitemid 23227563)
24. A.E. Heufelder, and R.S. Bahn Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy Experimental and Clinical Endocrinology 100 1992 62 67
25. K. Starkey, A. Janezic, and G. Jones Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo Journal of Molecular Endocrinology 30 2003 369 380 (Pubitemid 36722625)
26. R.S. Bahn, C.M. Dutton, and N. Natt Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy Journal of Clinical Endocrinology and Metabolism 83 1998 998 1002 (Pubitemid 28496482)
27. I.M. Wakelkamp, O. Bakker, and L. Baldeschi TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients Clinical Endocrinology 58 2003 280 287 (Pubitemid 36308115)
28. R.W. Valyasevi, D.Z. Erickson, and D.A. Harteneck Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor Journal of Clinical Endocrinology and Metabolism 84 1999 2557 2562
29. M.W. Szkudlinski, V. Fremont, and C. Ronin Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships Physiological Reviews 82 2002 473 502 (Pubitemid 34654459)
30. L. Duprez, J. Parma, and S. Costagliola Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain FEBS Letters 409 1997 469 474 (Pubitemid 27285907)
31. C.R. Chen, P. Pichurin, and Y. Nagayama The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim Journal of Clinical Investigation 111 2003 1897 1904 (Pubitemid 38057734)
32. L. Schwarz-Lauer, P.N. Pichurin, and C.R. Chen The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors Endocrinology 144 2003 1718 1725 (Pubitemid 36543308)
33. R. Latif, K. Michalek, and T.F. Davies Subunit interactions influence TSHR multimerization Molecular Endocrinology 24 2010 2009 2018
34. S.A. Morshed, R. Latif, and T.F. Davies Characterization of thyrotropin receptor antibody-induced signaling cascades Endocrinology 150 2009 519 529
35. F. Cetani, M. Tonacchera, and G. Vassart Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors FEBS Letters 378 1996 27 31 (Pubitemid 26007871)
36. J.L. Meinkoth, A.S. Alberts, and W. Went Signal transduction through the cAMP-dependent protein kinase Molecular and Cellular Biochemistry [Review] 127-128 1993 179 186 (Pubitemid 24032664)
37. G. Vassart, and J.E. Dumont The thyrotropin receptor and the regulation of thyrocyte function and growth Endocrine Reviews 13 1992 596 611
38. K. Michalek, S.A. Morshed, and R. Latif TSH receptor autoantibodies Autoimmunity Reviews 9 2009 113 116
39. B. Rapoport, and S.M. McLachlan The thyrotropin receptor in Graves' disease Thyroid 17 2007 911 922 (Pubitemid 350071596)
40. S.A. Morshed, T. Ando, and R. Latif Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades Endocrinology 151 2010 5537 5549
41. R.S. Bahn Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease Journal of Clinical Endocrinology and Metabolism [Review] 88 2003 1939 1946 (Pubitemid 36549860)
42. S. Kumar, A. Leontovich, and M. Coenen Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis Journal of Clinical Endocrinology and Metabolism 90 2005 4730 4735 (Pubitemid 41159365)
43. M. Lantz, T. Vondrichova, and H. Parikh Overexpression of immediate early genes in active Graves' ophthalmopathy Journal of Clinical Endocrinology and Metabolism 90 2005 4784 4791 (Pubitemid 41159372)
44. S. Kumar, S. Nadeem, and M.N. Stan A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy Journal of Molecular Endocrinology 46 2011 155 163
45. S. Kumar, R. Schiefer, and M.J. Coenen A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts Thyroid [Research Support, N.I.H., Extramural] 20 2010 59 65
46. L. Zhang, T. Bowen, and F. Grennan-Jones Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction Journal of Biological Chemistry 284 2009 26447 26455
47. L. Zhang, G. Baker, and D. Janus Biological effects of thyrotropin receptor activation on human orbital preadipocytes Investigative Ophthalmology and Visual Sciences 47 2006 5197 5203 (Pubitemid 46723765)
48. S. Meran, D. Thomas, and P. Stephens Involvement of hyaluronan in regulation of fibroblast phenotype Journal of Biological Chemistry 282 2007 25687 25697 (Pubitemid 47372811)
49. L.A. Kaback, and T.J. Smith Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy Journal of Clinical Endocrinology and Metabolism 84 1999 4079 4084 (Pubitemid 30644198)
50. J. Monslow, J.D. Williams, and N. Norton The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers International Journal of Biochemistry and Cell Biology 35 2003 1272 1283 (Pubitemid 36577317)
51. J.C. Lewthwaite, E.R. Bastow, and K.J. Lamb A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation Journal of Biological Chemistry 281 2006 11011 11018 (Pubitemid 43855524)
52. A. Kultti, R. Karna, and K. Rilla Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt Journal of Biological Chemistry 285 2010 22901 22910
53. T.J. Smith, and N. Hoa Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor Journal of Clinical Endocrinology and Metabolism 89 2004 5076 5080 (Pubitemid 39391451)
54. C.J. van Zeijl, E. Fliers, and C.J. van Koppen Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients Thyroid 20 2010 535 544
55. C.J. van Zeijl, E. Fliers, and C.J. van Koppen Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways Thyroid 21 2011 169 176
56. S. Kumar, S. Iyer, and H. Bauer IGF-1 receptor blockade inhibits hyaluronan synthesis induced by a stimulatory thyrotropin receptor antibody in Graves' orbital fibroblasts Thyroid 21 Suppl. 1 2011 [Abstract]
57. S. Mueller, G. Kleinau, and M.W. Szkudlinski The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor Journal of Biological Chemistry 284 2009 16317 16324
58. B. Rapoport, N.A. Takai, and S. Filetti Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue Journal of Clinical Endocrinology and Metabolism 54 1982 1059 1062 (Pubitemid 13243721)
59. T.J. Smith Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacological Reviews 62 2010 199 236
60. D. LeRoith, H. Werner, and D. Beitner-Johnson Molecular and cellular aspects of the insulin-like growth factor I receptor Endocrine Reviews 16 1995 143 163
61. J. Riedemann, and V.M. Macaulay IGF1R signaling and its inhibition Endocrine Related Cancer 13 Suppl. 1 2006 S33 S43
62. D. Aubin, A. Gagnon, and A. Sorisky Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture International Journal of Obesity (London) 29 2005 1006 1009 (Pubitemid 41076243)
63. W. Minish, A. Eckstein, and N. Dehina Detection of autoantibodies against the insulin-like growth factor-1 receptor in patients with Graves' orbitopathy by luminescent immunoprecipitation analysis Proc International thyroid Congress, Paris, France 39 2010 (Abstract OC-074)
64. S. Tsui, V. Naik, and N. Hoa Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease Journal of Immunology 181 2008 4397 4405
65. L.D. Kohn, F. Alvarez, and C. Marcocci Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease Annals of the New York Academy of Sciences 475 1986 157 173 (Pubitemid 16040506)
66. D. Tramontano, G.W. Cushing, and A.C. Moses Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG Endocrinology 119 1986 940 942 (Pubitemid 16048857)
67. S. Kumar, M. Coenen, and S. Demary IGF-1 receptor blockade inhibits Akt phosphorylation induced by a stimulatory thyrotropin receptor antibody in Graves' orbital preadipocyte fibroblasts Proc 14th International thyroid Congress, Paris, France 31 2010 (Abstract OC-044)
68. T.E. Adams, N.M. McKern, and C.W. Ward Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor Growth Factors 22 2004 89 95 (Pubitemid 38923312)
69. W.M. Wiersinga Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? Journal of Clinical Endocrinology and Metabolism 96 2011 2386 2394
70. S. Neumann, G. Kleinau, and S. Costanzi A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism Endocrinology 149 2008 5945 5950
71. S. Neumann, E. Eliseeva, and J.G. McCoy A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor Journal of Clinical Endocrinology and Metabolism 96 2011 548 554